Jaco Fishenfeld
Internal Medicine · San Jose, CANPI 1689639577
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,976 and has fallen 95.9% since, to $121 in 2024. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $55.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$517
- Pfizer$505
- GSK$328
- AstraZeneca$326
- Amarin Pharma, Inc.$313
- Boehringer Ingelheim$305
- plus $2K from 13 others
What the payments were for
- Food & beverage$4,08698%
- Education$932%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $517 |
| Pfizer | 9 | $505 |
| GSK | 6 | $328 |
| AstraZeneca | 6 | $326 |
| Amarin Pharma, Inc. | 12 | $313 |
| Boehringer Ingelheim | 9 | $305 |
| Merck | 2 | $250 |
| Sanofi-aventis U.S. LLC | 2 | $250 |
| E.r. Squibb & Sons, L.L.C. | 2 | $229 |
| Teva Pharmaceuticals USA, Inc. | 5 | $212 |
| Lilly USA, LLC | 5 | $159 |
| Johnson & Johnson | 2 | $139 |
| AbbVie | 1 | $125 |
| Akcea Therapeutics, Inc. | 1 | $125 |
| Bayer | 1 | $121 |
| Intuitive Surgical | 1 | $95 |
| Livanova USA, Inc. | 1 | $84 |
| Mylan Specialty L.p. | 2 | $57 |
| Esperion Therapeutics, Inc. | 2 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$502
- Vascepa$254
- STEGLATRO$250
- SOLIQUA 100/33$250
- TRELEGY ELLIPTA$247
- Ozempic$231
- FASENRA$131
- FARXIGA$125
- TEGSEDI$125
- Xultophy 100/3.6$125
- JARDIANCE$125
- Kerendia$121
- Tresiba$118
- INVOKANA$114
- AJOVY$105
How this compares
$4,180 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Jose
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.